ADC Therapeutics S.A. (ADCT)
NYSE · Healthcare
ADC Therapeutics S.A. Cash on Hand 2022–2025
ADC Therapeutics S.A. annual cash on hand history from 2022 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- ADC Therapeutics S.A. cash on hand as of December 31, 2025: 261.3M, a 4.17% increase year-over-year.
- ADC Therapeutics S.A. cash on hand for 2025 were 261.3M, a 4.17% increase from 2024.
- ADC Therapeutics S.A. cash on hand for 2024 were 250.9M, a 9.95% decrease from 2023.
- ADC Therapeutics S.A. cash on hand for 2023 were 278.6M, a 14.66% decrease from 2022.
- ADC Therapeutics S.A. cash on hand for 2022 were 326.4M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| ADC Therapeutics S.A. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $261 |
| 2024 | $251 |
| 2023 | $279 |
| 2022 | $326 |
ADC Therapeutics S.A. Cash on Hand — FAQ
ADC Therapeutics S.A. (ADCT) cash on hand over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADCT's cash on hand history?
The chart and table above show ADC Therapeutics S.A.'s cash on hand by year and by quarter, including the growth rate.